![Ruth Wolfson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ruth Wolfson worked as the Senior Vice President of Quality & Regulatory Affairs at Kamada Ltd. from 2004 to 2018.
Prior to that, she was the Head of Regulatory Affairs at Interpharm Laboratories Ltd. from 1989 to 2004.
Dr. Wolfson received her undergraduate and graduate degrees from The Hebrew University of Jerusalem and her doctorate from the Weizmann Institute of Science.
Anciens postes connus de Ruth Wolfson
| Sociétés | Poste | Fin |
|---|---|---|
| KAMADA LTD. | Directeur Technique/Scientifique/R&D | 02/01/2018 |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Conseiller Juridique Général | 01/01/2004 |
Formation de Ruth Wolfson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Choisissez Zonebourse 
